Skip to main content
. 2021 Nov 12;118(49):e2112457118. doi: 10.1073/pnas.2112457118

Table 1.

Viruses reported to use NRPs as cellular entry factors

Virus NRP Other receptor Viral NRP-binding protein Furin cleavage site Infected cell lines and cells in vivo Viral family Genome Host Disease Refs.
SARS-CoV-2 NRP-1 ACE2 S Yes HEK,* Caco2, Calu-3 Coronaviridae +RNA Human SARS 33, 34
HTLV1 NRP-1 Glut-1, HSPG Env Yes HeLa, DCs, T cells Retroviridae +RNA/DNA Human T cell leukemia 35, 36
EBV NRP-1 Ephr-A2 gB Yes Nasopharyngeal epithelial cells Herpesviridae DNA Human Nasopharyngeal cancer, lymphomas, mononucleosis 37, 38
mCMV NRP-1 n.d. n.d. n.d. Endothelial cells Herpesviridae DNA Mouse Mostly asymptomatic 39
hCMV NRP-2 CD46 Pentamer n.d. Nasopharyngeal epithelial and endothelial cells Herpesviridae DNA Human Birth complications, mononucleosis 40
LUJV NRP-2 CD63/LAMP1 GP n.d. Hap1, HEK, endothelial Arenaviridae −RNA Human Fatal hemorrhagic fever 41, 42

SARS, severe acute respiratory syndrome; DCs, dendritic cells; n.d., not determined.

*HEK cells are susceptible to SARS-CoV-2 only after exogenous expression of ACE2 and TMPRSS2.